Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

BioVendor Benefits from Using SCIENION’s Integrated Product Portfolio

Published: Tuesday, July 09, 2013
Last Updated: Tuesday, July 09, 2013
Bookmark and Share
Combined sciDROP PICO and sciDROP NANO technologies used for developing multiplex tests in microtiter plates.

SCIENION AG and BioVendor Laboratorni medicina a.s. have announced that BioVendor is using SCIENION’s complementary product portfolio for the production and detection of immunoassays.

Czech Republic Brno-based BioVendor Laboratorni medicina a.s. produces and distributes medical equipment and medical research products for international markets.

In its Research & Diagnostics Products division, BioVendor focuses on developing and manufacturing in vitro diagnostic and research-use only immunoassays, antibodies and recombinant proteins.

The company has begun developing its immunoassays using SCIENION’s integrated product portfolio including consumables such as sciPLEXPLATES, the sciFLEXARRAYER dispenser configured with both sciPICO and the new sciDROP NANO option, as well as the sciREADER CL for detection of assay results.

Dr. Viktor Růžička, CEO of BioVendor Laboratorni medicina a.s., comments: “Miniaturization and automation are key to our immunoassay production and the sciFLEXARRAYER has proven itself to be a state-of-the-art instrument for precise low volume liquid handling. We use it for developing new multiplex tests in microtiter plates to offer our customers cost-effective tools for parallel analytics. First application examples are multiplex IVD tests for the detection of borrelia infections as borreliosis can become a severe disease if not diagnosed early.”

Růžička also mentions another reason for choosing SCIENION technology: “We are spotting sensitive biological materials such as antigens and antibodies. Temperature is one of the factors that can have an impact of the functionality of these molecules. For us it is an important benefit of the sciFLEXARRAYER that the spotting head does not produce heat - especially as we manufacture tests in large quantities. Furthermore, SCIENION offers a cooling unit for source plates and targets.”

And finally he appreciates that SCIENION provides complete solutions for the automated production and detection of immunoassays because this facilitates work flow and enables advanced performance as products optimally complement each other.

Dr. Holger Eickhoff, CEO of SCIENION AG, states: “BioVendor has become a leading manufacturer of immunoassays for a wide range of applications. The company is known for many innovative products that are unique to the market. We are very pleased that BioVendor has selected SCIENION equipment for assay development and production. From the very start of our collaboration, BioVendor utilizes almost the complete range of our integrated product portfolio. I am confident that this decision will pay off for the company.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
SCIENION and Innopsys Agree on a Joint Product Offering for RPPA
Added value for customers combining technologies of both companies into a complete assay solution.
Tuesday, March 26, 2013
Genalyte Teams with Scienion to Provide sciFLEXARRAYER Dispensers
Scienion’s automated liquid handling dispenser complements the simplicity, speed and flexibility of the Maverick multiplexed system.
Thursday, September 20, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos